Tomoya Namekawa, Ryotaro Nishi, Toshiyuki Hori (Life sciences, Ritsumeikan Univ., Shiga, Japan)
Session information
Poster Session
Fri. Oct, 12
Poster Session 1-4 AML: Basic
Fri. Oct 12, 2018 5:50 PM - 6:30 PM Poster1 (Osaka International Convention Center, 3F Event Hall)
Chair: Shinya Kimura (Div. Hematology, Res Dis, Oncology, Saga University)
Yoshiaki Chinen1, Yohei Nakaya3, Haruna Naito2, Ayumi Honda2, Taku Tsukamoto1, Yuji Shimura1, Tsutomu Kobayashi1, Shigeo Horiike1, Junya Kuroda1 (1.Div., Hematol., Oncol., Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Discovery Research Labs. Nippon Shinyaku Co., Ltd., japan, 3.NS Pharma, Inc., USA)
Yusuke Takase1, Masaya Ueno1, Kumiko Ohta1, Kyoko Fuse1,2, Yuki Nishida3, Kensuke Kojima3, Atsushi Hirao1 (1.Cancer Research Institute, Kanazawa University, Kanazawa, Japan, 2.Department of Hematology, Endocrinology and Metabolism, Niigata University, Niigata, Japan, 3.Department of Internal Medicine, Saga University, Saga, Japan)
Yoshitaka Sunami1,2, Marito Araki3, Seiji Yamamoto4, Yoshiyuki Horiuchi4, Kazuya Tsujioka4, Kaoru Mogushi5, Misa Imai1, Soji Morishita3, Akimichi Ohsaka3, Norio Komatsu1 (1.Department of Hematology, Juntendo University, Tokyo, Japan, 2.Division of Carcinogenesis, The Cancer institute of JFCR, Tokyo, Japan, 3.Transfusion Medicine and Stem Cell Regulation, Juntendo University, Tokyo, Japan, 4.Research & Development Center, Fuso Pharmaceutical Industries, LTD, Osaka, Japan, 5.Intractable Disease Research Center, Juntendo University, Tokyo, Japan)
Masahiro Yoshida1,3, Hiroto Horiguchi1, Shohei Kikuchi1, Satoshi Iyama1, Masahiro Maeda3, Junji Kato2, Masayoshi Kobune1 (1.Department of Hematology., Sapporo Medical Univ., Sapporo, Japan, 2.Department of Medical Oncology., Sapporo Medical Univ., Sapporo, Japan, 3.Department of Hematology/Oncology, STEEL MEMORIAL MURORAN HOSPITAL)
Koichiro Maie1, Raksha Shrestha1, Mamiko Sakata-Yanagimoto1, Motohiko Oshima2, Yaeko Nakajima-Takagi2, Hirotaka Matsui3, Takayasu Kato1, Hideharu Muto1, Enguerran Mouly4, Olivier A. Bernard4, Haruhiko Koseki5, Atsushi Iwama2, Shigeru Chiba1 (1.Hematol., Univ. of Tsukuba, Tsukuba, Japan, 2.Cell. and Mol. Med., Chiba Univ., Chiba, Japan, 3.Mol. Lab. Med., Kumamoto Univ., Kumamoto, Japan, 4.INSERM U1170, Inst. Gustave Roussy, Villejuif, France, 5.RIKEN Ctr. Integr. Med. Sci., Yokohama, Japan)
Kim H. Hawk/Kim1,2, Yoo Kawi Han1, Lee Jea Hoon1, Heo Sook-Kyoung2, Noh Eui-Kyu2, Jo Jae-Cheol2, Choi Yunsuk2 (1.Division of Hematology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea, 2.Division of Hematology, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea, 3.Biomedical Research Center, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea)
Jiaxiong Tan1,2, Shaohua Chen2, Jingying Huang2, Youchun Chen2, Zhi Yu1, Yuhong Lu1, Yangqiu Li1,2,3 (1.Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China, 2.Institute of Hematology, Medical College, Jinan University, Guangzhou, People's Republic of China, 3.Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, People's Republic of China)